Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice

Nature
R L O'BrienU Storb

Abstract

Initial studies of somatically acquired mutations in immunoglobulin V regions from hybridomas and myelomas that are not derived from joining aberrations, suggested a controlled and specific hypermutation process, because spontaneous mutation rates observed for other genes are extremely low. Some evidence for the idea that mutations are introduced during V-gene rearrangement came from the clustering of mutations at the joining sites, from the absence of mutations in unrearranged V genes and from the low level of mutations in only partially (D-J) rearranged nonproductive heavy-chain alleles. Another model in which mutations accumulate with each cell division, rather than being introduced all at once, was supported by the finding that immunoglobulin genes of hybridomas derived from a single mouse frequently had several mutations in common, and so might be derived from the same precursor cell whose daughters then accumulated additional mutations. But the common mutations in some cases could be due to as yet unidentified related germline genes, or could represent the effect of antigen selection for certain amino acids. To try to detect hypermutation in the absence of V-gene rearrangement, we isolated B lymphocytes with endogenous he...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T T WuH Bilofsky
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·M Weigert, R Riblet
Jan 1, 1977·Immunological Reviews·D S SecherK Adetugbo
Jul 1, 1978·Nucleic Acids Research·H F Tabak, R A Flavell
Aug 1, 1986·The Journal of Experimental Medicine·U StorbR L Brinster
Dec 1, 1985·The Journal of Experimental Medicine·R M PerlmutterL Hood
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L WysockiM L Gefter
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M WablC Steinberg
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D McKeanM Weigert
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P J Gearhart, D F Bogenhagen
Jan 1, 1980·Methods in Enzymology·A M Maxam, W Gilbert
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S RudikoffM Heller
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H K GershenfeldR Joho
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S H ClarkeS Rudikoff

❮ Previous
Next ❯

Citations

Oct 30, 1999·European Journal of Immunology·S J FosterP E Lipsky
Apr 1, 1995·Current Opinion in Immunology·M S Neuberger, C Milstein
Apr 1, 1996·Current Opinion in Immunology·U Storb
Mar 30, 1999·Mutation Research·R S HarrisN Maizels
Mar 22, 2002·Nature Reviews. Immunology·P J Gearhart, R D Wood
Apr 1, 1992·Immunology and Cell Biology·E J Steele
Jul 27, 2006·Nature Reviews. Immunology·Valerie H Odegard, David G Schatz
Jan 9, 2008·Immunology and Cell Biology·Michael S Neuberger
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lucia KatoTasuku Honjo
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J DurdikE Selsing
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A UmarP J Gearhart
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·N SarvetnickR Lerner
Jul 1, 1990·The Journal of Experimental Medicine·J HackettU Storb
Jul 11, 1992·The Journal of Experimental Medicine·J HackettU Storb
Feb 1, 1993·The Journal of Experimental Medicine·J SohnE Selsing
Apr 25, 1994·Nucleic Acids Research·S D WagnerM Brüggemann
Mar 10, 2001·Cold Spring Harbor Symposia on Quantitative Biology·U StorbT E Martin
May 29, 1998·Immunological Reviews·N S GreenM D Scharff
May 29, 1998·Immunological Reviews·U StorbT E Martin
Mar 3, 2007·Annual Review of Biochemistry·Javier M Di Noia, Michael S Neuberger
Jan 1, 1996·Annual Review of Immunology·S D Wagner, M S Neuberger
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ai KotaniTasuku Honjo
Aug 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Diana RonaiMatthew D Scharff
Jan 20, 1997·The Journal of Experimental Medicine·M D ScharffN S Green
Jun 1, 1989·Risk Analysis : an Official Publication of the Society for Risk Analysis·J C Cordaro
Oct 1, 1987·Immunological Reviews·T LeandersonR Rajasekar
Apr 2, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Karuna Ganesh, Michael S Neuberger
Jul 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A TerauchiT Azuma
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gary S ShapiroLawrence J Wysocki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.